🔗 Share this article

Treasury head Reeves has stated she is preparing "targeted measures to tackle household expense challenges" in the forthcoming financial statement.

Speaking to the BBC, she noted that reducing price rises is a joint task of both the administration and the central bank.

The United Kingdom's price growth is projected to be the most elevated among the G7 advanced economies this calendar year and the following year.

Potential Utility Cost Measures

Sources suggest the government could intervene to reduce utility costs, for example by reducing the current 5% rate of value-added tax charged on energy supplies.

Another option is to cut some of the policy costs presently included in bills.

Fiscal Limitations and Expert Predictions

The administration will obtain the next draft from the official forecaster, the OBR, on the start of the week, which will show how much space there is for these measures.

The consensus from most experts is that Reeves will have to announce higher taxes or expenditure reductions in order to fulfill her self-imposed borrowing rules.

Previously on Thursday, estimates showed there was a £22 billion shortfall for the Treasury chief to fill, which is at the more modest range of forecasts.

"It is a collective task between the central bank and the administration to continue tackling some of the sources of inflation," Reeves told reporters in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Revenue Pledges and Global Concerns

While a great deal of the focus has been on expected tax increases, the chancellor said the most recent information from the fiscal watchdog had not altered her commitment to election pledges not to increase rates on earnings tax, VAT or social security contributions.

She blamed an "unpredictable global environment" with increasing geopolitical and trade tensions for the Budget tax moves, likely to be directed on those "wealthiest."

International Trade Disputes

Addressing concerns about the UK's commercial links with the Asian nation she said: "Our security interests invariably come first."

Recent declaration by Chinese authorities to tighten export controls on rare earths and other materials that are key for advanced tech manufacturing led US President Donald Trump to suggest an additional 100% import tax on imports from China, increasing the possibility of an all-out trade war between the two global powers.

The US Treasury Secretary labeled China's action "commercial pressure" and "a international production power grab."

Asked about considering the American proposal to join its conflict with the Asian nation, the Chancellor said she was "very concerned" by China's measures and called on the Beijing authorities "not to put up barriers and restrict access."

She said the action was "damaging for the world economy and causes additional obstacles."

"It is my opinion there are areas where we need to challenge China, but there are also valuable chances to trade with Chinese markets, including financial services and other sectors of the economy. We've got to get that balance appropriate."

The chancellor also affirmed she was collaborating with G7 counterparts "regarding our own critical minerals plan, so that we are less reliant."

NHS Drug Costs and Funding

The Chancellor also admitted that the price the National Health Service pays for pharmaceuticals could rise as a result of current discussions with the US government and its pharmaceutical firms, in return for lower tariffs and capital.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or canceling projects in the UK, with several blaming the modest returns they are getting.

Recently, the government science advisor said the cost the health service spends on drugs would must increase to stop businesses and pharmaceutical investment departing from the United Kingdom.

The Chancellor told the BBC: "We have seen because of the pricing regime, that drug testing, recent pharmaceuticals have not been available in the UK in the way that they are in other European countries."

"Our aim is to guarantee that patients receiving care from the NHS are can access the top critical medicines in the world. And so we are reviewing these issues, and... looking to attract increased investment into Britain."